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In 1961 CS Lewis observed that grief felt like fear, or being concussed, with “an invisible 
blanket between the world and me” (Lewis, 1961).  During his exploration of grief, Lewis observes 
that from feelings one can move to thinking, that is, to apply the rational self as a point from which 
to move forward.  And so to prostate cancer.   
The global burden of prostate cancer is escalating with over 1.2 million men diagnosed each 
year (Bray et al., 2018).  The face of prostate cancer has changed over the past three decades since 
the advent of the prostate-specific antigen test and the promise of early detection and cure 
(Schroder, Hugosson, Carlsson, et al., 2012; Schroder, Hugosson, Roobol, et al., 2012), and new 
approaches to the treatment of advanced disease (Emmett et al., 2017). Clinical research and 
technological advances have expanded treatment possibilities for these men - theranostics and 
personalised medicine offer new hope (Huey, Hawk, & Offodile, 2019). However, the personal 
experience of prostate cancer, and the feelings that surround prostate cancer, are connected to 
physical, social, psychological, and relationship challenges that for many men will be long term, if not 
life-long (Chambers, Ng, et al., 2017; Chambers, Occhipinti, et al., 2019).  The data is clear. After 
diagnosis up to one in four men experience anxiety and up to one in five report depression (Watts et 
al., 2015). Heightened distress occurs across all treatment approaches, exacerbated when disease or 
symptom effects are advanced (Chambers, Ng, et al., 2017; Coughlin et al., 2018; Meissner, 
Herkommer, Marten-Mittag, Gschwend, & Dinkel, 2017). Risk of suicide is increased after  a 
diagnosis of prostate cancer by comparison with controls (Bill-Axelson et al., 2010; Carlsson et al., 
2013; Dalela et al., 2016), particularly in the first six to twelve months after diagnosis (Guo et al., 
2018; Smith et al., 2018).  Unmet needs for support for psychological care are widely prevalent 
(Hyde et al., 2016; Smith et al., 2007).  For many, the diagnosis of prostate cancer will generate 
strong feelings and a life permanently changed. 
And so to thinking, to act.  
Brief distress screening for people with cancer is an accepted standard in oncology care 
(Holland, Watson, & Dunn, 2011); it is well validated in men with prostate cancer (Chambers, 
Zajdlewicz, Youlden, Holland, & Dunn, 2014); and evidence-based and accessible psychosocial 
interventions have been developed (Chambers, Hyde, et al., 2017; Crawford‐Williams et al., 2018).  
Psychosocial care is at the core of best practice survivorship care (Andersen et al., 2014). Unless men 
experiencing high levels of distress are identified within the care pathway, and referred for 
intervention or support, they are unlikely to receive the care they need (Chambers & Heathcote, 
2018).  To date, in Australia and likely elsewhere, distress screening for men with prostate cancer 
has not been universally implemented and so, many men will have their psychological needs left 
both unnoticed and unaddressed.  By and large, psycho-oncology research has not addressed 
implementation and systems-based interventions that focus on sustainable improvements in 
psychosocial care are scant (Sanson-Fisher et al., 2019). Consonant with this, for men with prostate 
cancer and their partners, psychosocial and survivorship care implementation studies are largely 
absent (Chambers, Hyde, et al., 2017; Crawford‐Williams et al., 2018). Herein lies the problem.  
The Prostate Cancer Foundation of Australia and Australian National Health and Medical 
Research Council Centre for Research Excellence in Prostate Cancer Survivorship partnered with key 
Australian medical, nursing and research leaders to develop a position statement on screening for 
distress and on providing psychosocial care for men with prostate cancer (available at 
https://www.pcfa.org.au/). The statement was launched on September 11th 2019 in Canberra to 
encourage and guide advocacy to enhance psychosocial outcomes for men and their families as well 
as cancer survivorship more broadly. Importantly, the statement is endorsed by the Urological 
Society of Australia and New Zealand; Australia and New Zealand Urological Nursing Society; Royal 
Australian and New Zealand College of Radiologists; Medical Oncology Group of Australia; Australia 
and New Zealand Uro-genital and Prostate Cancer Trials group; European Association of Urology 
Nurses and universities across Australia.  The statement recommends: 
1. After the diagnosis of prostate cancer and regularly through treatment and 
surveillance men who have been diagnosed with prostate cancer should be screened for distress and 
their psychological and quality of life concerns should be explored 
2. Men who have high levels of distress should be further evaluated for anxiety and/or 
depression and evidence of suicidality 
3. Men who have high distress or need for support should be referred to evidence-
based intervention matched to their individual needs and preferences for support 
4. Research is needed to develop effective methods to identify partners of men with 
prostate cancer with high distress or who are at risk of high distress as well as effective interventions 
for partners and for couples where the man has a diagnosis of prostate cancer 
5. Investment in prostate cancer survivorship research is a national health priority 
It does not seem a difficult or insurmountable health system change to screen for distress 
after a diagnosis of cancer and to refer to relevant support, yet implementation continues to lag 
(Lazenby, Tan, Pasacreta, Ercolano, & McCorkle, 2015). The administration time for a single item 
distress thermometer and problem checklist can be measured in brief minutes. But most 
importantly, this brief screen initiates the patient’s self-appraisal of distress, and guides clinical staff 
not only on the level of distress, but also on the source or sources of concern for the man. An 
evidence-based monograph has been produced to guide the health sector in taking action to 
implement screening for distress and referral for men with prostate cancer to psychosocial health 
care resources (Chambers, Galvão, et al., 2019; available at https://www.pcfa.org.au/).  Learning 
tools have been developed and are in trial.  Recently, Lazenby and colleagues reported the 
successful dissemination and implementation of psychosocial distress screening at 72 cancer centres 
in North America (Lazenby et al., 2019).  The involvement of key stakeholder groups was crucial to 
the success of this program, and with this involvement came the commitment of resources. 
Awareness, education, and skills training to support actual implementation needs to be context-
relevant and accessible.  Our approach is consistent with this. 
For men with prostate cancer in our setting, the first key steps for implementation are in play: 
a published and context-relevant evidence base developed with the support of key stakeholders by a 
dedicated community-based consumer organisation, the Prostate Cancer Foundation of Australia, 
advocating independently for change.  Position statements are only of value when adopted into 
routine practice, and therein lies the challenge: we must move beyond feeling to thinking and acting. 
Returning to CS Lewis (1961), the observation that “attention is an act of will”, and “intelligence in 
action is will par excellence”. This is our challenge as health professionals in oncology. We have the 
knowledge. Do we have the will? 
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